Seacall Nasal Spray.

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for use in specific patient populations as determined by clinical guidelines. Currently, there are no detailed indications or usage specifications provided. Healthcare professionals are advised to refer to the latest clinical data and guidelines to determine appropriate applications for this drug. There are no known teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The recommended dosage for the medication is a maximum of four administrations per day. Each dose should be separated by an interval of no less than four hours. Continuous use should not exceed seven days. Healthcare professionals should ensure that patients adhere to these guidelines to avoid potential adverse effects associated with prolonged use.

Contraindications

Use of this product is contraindicated in the following situations:

• In pediatric patients (children).

• In individuals with atrophic rhinitis.

• In patients experiencing nasal dryness.

Additionally, the product should not be used if there is a change in its character.

Warnings and Precautions

The use of this product is strictly limited to adults. It is imperative to note that sharing this container among multiple individuals may facilitate the transmission of infections.

General precautions must be observed to ensure safe usage. This product is contraindicated in children and should not be used in individuals with atrophic rhinitis or nasal dryness. Additionally, if there are any changes in the product's characteristics, its use should be discontinued immediately.

Patients are advised to stop using the product and consult a healthcare professional if they have a history of hypertension, coronary heart disease, hyperthyroidism, or if they are known to have allergies.

In the event of accidental ingestion, it is crucial to seek emergency medical assistance or contact a poison control center without delay.

Side Effects

Patients should be aware that the use of this product is intended for adults only. There is a risk of infection transmission if the container is used by more than one person.

In clinical practice, it is advised that patients discontinue use and consult a healthcare professional if they experience any of the following conditions: hypertension, coronary heart disease, hyperthyroidism, or if they have a history of allergies. These conditions may necessitate a reevaluation of the treatment approach to ensure patient safety and efficacy.

It is crucial for patients to remain vigilant regarding their health status while using this product and to seek medical advice if any of the aforementioned conditions are present.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Seacall Nasal Spray. (nasal spray). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should not use this product. It is important to keep the product out of reach of children. In the event of accidental ingestion, medical assistance should be sought immediately, or a poison control center should be contacted.

Geriatric Use

Elderly patients should be aware that this medication is intended for adult use only and is not recommended for children. Caution is advised when considering the use of this medication in geriatric patients, particularly those with pre-existing conditions such as hypertension, coronary heart disease, hyperthyroidism, or allergies.

It is essential for healthcare providers to monitor elderly patients closely for any adverse effects, especially in those with the aforementioned conditions. If any concerning symptoms arise, such as increased blood pressure or exacerbation of existing health issues, patients should discontinue use and consult their healthcare provider promptly.

Due to the potential for increased sensitivity to medications in the geriatric population, careful consideration and evaluation of the risks versus benefits should be undertaken before prescribing this medication to elderly patients.

Pregnancy

There is no specific information regarding the use of this medication during pregnancy. The prescribing information does not indicate any contraindications, safety concerns, dosage modifications, or special precautions for pregnant patients. Healthcare professionals should consider the lack of data when prescribing this medication to women of childbearing potential and weigh the potential benefits against any unknown risks to fetal outcomes. It is advisable to monitor pregnant patients closely if this medication is deemed necessary.

Lactation

The safety of this product in nursing mothers has not been established. Caution should be exercised when administered to a nursing woman. There is a potential for excretion in breast milk, and the effects on the nursing infant are unknown.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary significantly depending on the substance involved and the individual patient's characteristics. Symptoms of overdose can range from mild to severe and may include altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate assessment of the patient's condition is crucial. Recommended actions include:

1. Assessment and Monitoring: Conduct a thorough evaluation of the patient's vital signs, level of consciousness, and any presenting symptoms. Continuous monitoring may be necessary to detect any deterioration in the patient's condition.

2. Supportive Care: Initiate supportive measures as needed, which may include airway management, oxygen supplementation, intravenous fluids, and medications to stabilize vital signs.

3. Decontamination: If the overdose is recent and the patient is alert and able to protect their airway, consider activated charcoal administration to limit further absorption of the substance. Gastric lavage may be indicated in certain cases, but only if performed within a suitable time frame and under appropriate clinical circumstances.

4. Specific Antidotes: If applicable, administer specific antidotes as indicated for the substance involved in the overdose. Familiarity with the pharmacology and antidote options for commonly encountered agents is essential.

5. Consultation: Engage with a poison control center or toxicology expert for guidance on management strategies tailored to the specific overdose scenario.

6. Documentation: Ensure thorough documentation of the incident, including the substance involved, estimated dose, time of ingestion, and all interventions performed.

In summary, while no specific overdosage information is provided, healthcare professionals should be prepared to act swiftly and effectively in managing potential overdose situations, utilizing established protocols and resources to ensure optimal patient outcomes.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children. In the event of accidental ingestion, patients should seek medical help or contact a poison control center immediately.

Patients should be informed that this product is not recommended for use in children, individuals with atrophic rhinitis, or those experiencing nasal dryness. Additionally, patients should be cautioned against using the product if there are any changes in its character.

Healthcare providers should instruct patients to discontinue use and consult a doctor if they have a history of hypertension, coronary heart disease, hyperthyroidism, or if they are allergic to any components of the product.

While using this product, patients should be advised to avoid contact with the eyes and mouth. If they experience a burning sensation, redness, or swelling at the site of application, they should discontinue use and wash the area with water. Patients should consult a physician if these symptoms persist or worsen.

Storage and Handling

The product is supplied in a manner that ensures optimal preservation of its integrity. It should be shielded from light and stored in a sealed container. The recommended storage temperature is not to exceed 20℃. It is essential to keep the product in a cool place to maintain its efficacy and safety.

Additional Clinical Information

The product is administered topically, with a recommended frequency of no more than four times per day. There should be an interval of at least four hours between applications, and continuous use should not exceed seven days. Clinicians should advise patients to consult their physician or pharmacist if they are using other medications prior to using this product. No additional information is available regarding laboratory tests, abuse potential, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Seacall Nasal Spray., including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)